# JBHI论文contribution写法

**Conversation ID:** `6a190a87-bbdc-83ec-beee-f3bafe53d8ef`

**Model:** gpt-5-5-thinking

**Created:** 2026/5/29 11:40:16

**Last Updated:** 2026/5/29 11:45:29

---

## 👤 User (2026/5/29 11:40:11)

JBHI的论文的contribution list一般是怎么写的

---

## 🤖 Assistant (2026/5/29 11:40:15)

我会按 JBHI/IEEE 生物医学信息学论文的常见写法来回答，并核一下是否有期刊层面的明确要求，避免只凭印象。

---

## 🤖 Assistant (2026/5/29 11:40:47)

JBHI 里常见的 **contribution list** 一般指 Introduction 末尾的 “paper contributions”，不是作者分工。写法要偏 **技术贡献 + 医学/健康信息学价值 + 充分验证**。JBHI 的定位是 biomedical and health informatics，强调 information/communication technologies 与 healthcare、life sciences、biomedicine 的结合，论文通常要有理论分析、方法、技术开发或临床信息系统应用方面的原创内容。citeturn511772search8 IEEE Author Center 也强调 Introduction 要说明研究问题、重要性和 novelty，Discussion/Conclusion 不要夸大贡献。citeturn544842view0

### 一般放在哪里

通常放在 Introduction 最后一两段，Related Work/Problem Statement 之后，Paper Organization 之前：

> The main contributions of this work are summarized as follows:

然后列 **3–4 条** 最稳。2 条显得薄，5 条以上容易像堆卖点。

### JBHI 风格的 contribution 应该写什么

每条最好回答三个问题：

**我们做了什么？**  
**相比已有方法新在哪里？**  
**为什么对 biomedical/health informatics 有价值？**

常见结构是：

1. **Problem / formulation contribution**  
   你是否重新定义了一个临床/生物医学任务、提出了新框架、新假设、新学习范式。

2. **Method contribution**  
   你提出了什么模型、算法、模块、损失函数、多模态融合机制、隐私保护机制、可解释机制等。

3. **Data / system / application contribution**  
   你是否构建了数据集、标注协议、真实临床流程系统、可部署 pipeline、跨中心数据处理方案。

4. **Evaluation / clinical validation contribution**  
   你是否做了外部验证、跨数据集验证、消融实验、医生评估、统计显著性分析、泛化性/鲁棒性/公平性分析。

### 可直接套用的英文模板

```text
The main contributions of this work are summarized as follows:

1) We formulate [clinical/biomedical task] as [technical problem], enabling [specific benefit] under [realistic constraint].

2) We propose [method/model/framework], which integrates [key components] to address [specific limitation of prior work].

3) We develop/curate [dataset/system/pipeline] with [important properties], supporting [clinical or biomedical use case].

4) We conduct comprehensive experiments on [datasets/settings], including [external validation/ablation/clinical evaluation], demonstrating [performance/generalizability/interpretability] compared with [baselines].
```

### 更像 JBHI 的版本

```text
The contributions of this paper are threefold.

First, we propose a clinically motivated formulation for [task], which explicitly models [patient-level/temporal/multimodal/uncertainty] information that is often ignored in existing studies.

Second, we develop a [model/framework] that combines [component A] and [component B] to improve [prediction/segmentation/retrieval/decision support] while preserving [interpretability/privacy/computational efficiency].

Third, we perform extensive validation on [internal and external datasets], including ablation studies and comparisons with state-of-the-art methods, showing that the proposed approach achieves robust performance across [clinical sites/patient groups/modalities].
```

### 写的时候避免这些问题

不要写成：

> We propose a novel deep learning method.  
> We achieve better performance.  
> We conduct many experiments.

这太泛了。改成：

> We propose a cross-modal attention framework that aligns longitudinal EHR variables with imaging features for early disease-risk prediction.  
> We validate the framework on two independent cohorts and show improved calibration and external generalization over transformer- and CNN-based baselines.

### 判断一条 contribution 是否够强

你可以用这个标准检查：

> 如果把这一条删掉，审稿人是否还能清楚知道你的论文新在哪里？

如果删掉也不影响，那它不是 contribution，而只是工作内容。

### 作者贡献另算

如果你问的是 **Author Contributions / CRediT statement**，那通常不是 Introduction 里的 contribution list，而是说明每位作者做了什么。CRediT 是常见的作者贡献分类体系，包含 Conceptualization、Methodology、Software、Validation、Writing 等 14 类角色。citeturn705033search0 写法类似：

```text
A.B.: Conceptualization, Methodology, Software, Writing – original draft.
C.D.: Data curation, Validation, Formal analysis.
E.F.: Supervision, Funding acquisition, Writing – review & editing.
```

对 JBHI 投稿，我建议 Introduction 里的 contribution list 写 **3 条主贡献 + 1 条验证贡献**，不要只吹模型 SOTA，要把 **clinical relevance、generalization、interpretability/reproducibility** 写出来。

---

## 👤 User (2026/5/29 11:42:47)

JBHI的方法论论文的contribution list一般是怎么写的

---

## 🤖 Assistant (2026/5/29 11:42:51)

我会按 JBHI（IEEE Journal of Biomedical and Health Informatics）的论文风格来回答：先核对期刊要求，再结合方法论论文常见写法给你一个可直接套用的结构。

---

## 🤖 Assistant (2026/5/29 11:43:21)

你这里说的 **contribution list**，我理解为 Introduction 末尾的 “The main contributions are summarized as follows”，不是作者贡献声明。

JBHI 方法论论文一般写得很**工程化、问题导向、三点式**：先点出临床/生物医学任务里的痛点，然后列 2–4 条贡献。常见位置是在 Introduction 最后一段，放在 “The remainder of this paper is organized as follows” 前面。比如 JBHI 论文里 DSAL 在提出方法动机后列了三点：框架、核心准则、实验验证；M2FTrans 也是三点：总体策略、关键模块、针对缺失模态问题的机制；PDCC 也是三点：框架、样本选择分数、综合实验。citeturn681716view2turn681716view1turn681716view0

**最常见结构是：**

> The main contributions of this work/article/paper are summarized as follows:  
> • We propose a [framework/model/method] for [biomedical task/problem], which addresses [key challenge].  
> • We design/develop/introduce [key module/loss/criterion/strategy] to [mechanism], enabling [technical benefit].  
> • We conduct comprehensive experiments on [datasets/clinical cohorts] and compare with [SOTA/baselines]; results and ablation studies demonstrate [performance/robustness/efficiency/clinical relevance].

对 JBHI 的方法论论文来说，贡献点最好覆盖这三类：

**1. 方法框架贡献**  
不是简单说 “we use Transformer/CNN/GNN”，而是说你提出了什么完整框架，以及它解决哪个 biomedical health informatics 痛点。

例句：

> We propose a privacy-preserving source-free domain adaptation framework for cross-subject EEG classification, enabling knowledge transfer without accessing raw source-domain data.

**2. 核心技术模块贡献**  
这一条要写得具体。比如新的 loss、fusion strategy、sample selection criterion、uncertainty module、prompting strategy、graph construction、domain adaptation mechanism 等。JBHI 例子里 DSAL 写的是 “novel criterion for uncertainty evaluation”，PDCC 写的是 “comprehensive score” 用于选择 proxy-domain 样本，M2FTrans 写的是 modality-masked fusion transformer 和 learnable fusion tokens。citeturn681716view2turn681716view0turn681716view1

例句：

> We design a confidence-aware sample selection criterion that jointly considers prediction consistency and class-level reliability, improving the quality of pseudo-labeled target samples.

**3. 验证贡献**  
JBHI 很看重实验是否扎实：公开数据集、多中心/跨域/跨被试、SOTA 比较、消融实验、效率或临床相关性分析。DSAL 的第三点就是实验验证其减少标注成本和计算时间；PDCC 的第三点包括四个 EEG 数据集、SOTA 对比和中间过程分析。citeturn681716view2turn681716view0

例句：

> We evaluate the proposed method on three public datasets and one external clinical cohort, with comparisons against state-of-the-art methods and ablation studies demonstrating the effectiveness of each component.

一个比较像 JBHI 的完整模板：

> To address the above challenges, we propose **XXX**, a [brief description] framework for [task]. The main contributions of this article are summarized as follows:  
> • We propose **XXX**, a [method type] framework that addresses [biomedical challenge], enabling [main advantage].  
> • We design [module/loss/strategy] to [technical mechanism], which improves [robustness/generalization/interpretability/privacy/efficiency].  
> • We conduct comprehensive experiments on [datasets/settings], including [SOTA comparison/ablation/external validation], demonstrating that XXX achieves [main empirical benefit].

注意别写成这种空话：

> We propose a novel deep learning method.  
> We achieve good performance.  
> We conduct many experiments.

要改成：

> We propose a lesion-aware multi-scale fusion network for [task], explicitly modeling [biomedical structure/challenge].  
> We introduce [specific module] to reduce [specific failure mode].  
> Experiments on [dataset names] show improved [metric] under [clinically relevant setting], with ablation studies confirming the contribution of each module.

简单说：**JBHI 的 contribution list 不追求花哨，追求“问题—方法—机制—验证”清楚。三条最稳：一个总体框架，一个核心创新，一个实验/临床验证。**

